BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 19674071)

  • 1. Familial gastric cancer and Li-Fraumeni syndrome.
    Corso G; Pedrazzani C; Marrelli D; Pinto E; Roviello F
    Eur J Cancer Care (Engl); 2010 May; 19(3):377-81. PubMed ID: 19674071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of a novel germ line p53 mutation in familial gastric cancer in the Japanese population.
    Yamada H; Shinmura K; Okudela K; Goto M; Suzuki M; Kuriki K; Tsuneyoshi T; Sugimura H
    Carcinogenesis; 2007 Sep; 28(9):2013-8. PubMed ID: 17690113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer.
    Lehman TA; Haffty BG; Carbone CJ; Bishop LR; Gumbs AA; Krishnan S; Shields PG; Modali R; Turner BC
    Cancer Res; 2000 Feb; 60(4):1062-9. PubMed ID: 10706125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Li-Fraumeni syndrome: an inherited susceptibility to cancer.
    Evans SC; Lozano G
    Mol Med Today; 1997 Sep; 3(9):390-5. PubMed ID: 9302689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
    J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.
    Achatz MI; Olivier M; Le Calvez F; Martel-Planche G; Lopes A; Rossi BM; Ashton-Prolla P; Giugliani R; Palmero EI; Vargas FR; Da Rocha JC; Vettore AL; Hainaut P
    Cancer Lett; 2007 Jan; 245(1-2):96-102. PubMed ID: 16494995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A germ line mutation in exon 5 of the p53 gene in an extended cancer family.
    Law JC; Strong LC; Chidambaram A; Ferrell RE
    Cancer Res; 1991 Dec; 51(23 Pt 1):6385-7. PubMed ID: 1933902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome.
    Palmero EI; Achatz MI; Ashton-Prolla P; Olivier M; Hainaut P
    Curr Opin Oncol; 2010 Jan; 22(1):64-9. PubMed ID: 19952748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations.
    Finkova A; Vazna A; Hrachovina O; Bendova S; Prochazkova K; Sedlacek Z
    Cancer Genet Cytogenet; 2009 Aug; 193(1):63-6. PubMed ID: 19602465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
    Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA
    Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germ line BAX alterations are infrequent in Li-Fraumeni syndrome.
    Barlow JW; Mous M; Wiley JC; Varley JM; Lozano G; Strong LC; Malkin D
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1403-6. PubMed ID: 15298965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome.
    Tabori U; Nanda S; Druker H; Lees J; Malkin D
    Cancer Res; 2007 Feb; 67(4):1415-8. PubMed ID: 17308077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.
    Birch JM; Blair V; Kelsey AM; Evans DG; Harris M; Tricker KJ; Varley JM
    Oncogene; 1998 Sep; 17(9):1061-8. PubMed ID: 9764816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin.
    Bendig I; Mohr N; Kramer F; Weber BH
    Cancer Genet Cytogenet; 2004 Oct; 154(1):22-6. PubMed ID: 15381368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.
    Varley JM; McGown G; Thorncroft M; Santibanez-Koref MF; Kelsey AM; Tricker KJ; Evans DG; Birch JM
    Cancer Res; 1997 Aug; 57(15):3245-52. PubMed ID: 9242456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of de novo mutations in Li-Fraumeni syndrome.
    Gonzalez KD; Buzin CH; Noltner KA; Gu D; Li W; Malkin D; Sommer SS
    J Med Genet; 2009 Oct; 46(10):689-93. PubMed ID: 19556618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Li-Fraumeni syndrome].
    Frebourg T
    Bull Cancer; 1997 Jul; 84(7):735-40. PubMed ID: 9339200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infrequent germ-line mutation of the E-cadherin gene in Japanese familial gastric cancer kindreds.
    Iida S; Akiyama Y; Ichikawa W; Yamashita T; Nomizu T; Nihei Z; Sugihara K; Yuasa Y
    Clin Cancer Res; 1999 Jun; 5(6):1445-7. PubMed ID: 10389930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three germline mutations in the TP53 gene.
    Cornelis RS; van Vliet M; van de Vijver MJ; Vasen HF; Voute PA; Top B; Khan PM; Devilee P; Cornelisse CJ
    Hum Mutat; 1997; 9(2):157-63. PubMed ID: 9067756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inherited p53 gene mutations in breast cancer.
    Sidransky D; Tokino T; Helzlsouer K; Zehnbauer B; Rausch G; Shelton B; Prestigiacomo L; Vogelstein B; Davidson N
    Cancer Res; 1992 May; 52(10):2984-6. PubMed ID: 1581912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.